The Life Sciences and Health Care industry group strives to support clients in addressing challenges that impact the industry. As the life sciences and health care industry continues to evolve, professionals from across Deloitte's global network engage with clients to develop innovative solutions to help them achieve their respective business missions and move closer to their vision for the future. Contact the LSHC group to learn more about Deloitte's global industry practice.
|Transformation beyond reform: A changing life sciences & health care industry
In conjunction with the Financial Times/Deloitte 2013 Health Care & Life Sciences conference, explore what lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform.
|Health care reform and life sciences: Threat, opportunity or both?
New survey shows enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts on the life sciences industry from health care reforms around the world.
|Deloitte ranked #1 in life sciences
Deloitte has been ranked number one in Life Sciences consulting services by Kennedy Information based on revenue. Ranking covers the four subsectors: pharmaceutical, biotechnology, medical device, and drug distribution.
|2013 Deloitte survey of U.S. physicians: Perspectives about health care reform
U.S. physicians are concerned future of medical profession may be in jeopardy and performance of the U.S. health care system is suboptimal, but the Affordable Care Act will address this.
|2013 Global life sciences sector outlook
New report examines the current state of the global life sciences industry, explores top issues, reviews activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2013 and beyond.